Related Experiment Video
Updated: Jun 14, 2026

12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
6.3K
Transanal total mesorectal excision: the Slagelse experience 2013-2019
Sharaf Karim Perdawood1, Jens Kroeigaard2, Marianne Eriksen2
1Department of Gastrointestinal Surgery, Slagelse Hospital, Faelledvej 11, 4200, Slagelse, Denmark. sharaf73@hotmail.com.
Surgical Endoscopy
|February 20, 2020
Summary
Transanal total mesorectal excision (TaTME) shows acceptable short-term outcomes for rectal cancer, with a 4.7% local recurrence rate. Longer follow-up is needed to confirm long-term oncologic results after this minimally invasive procedure.
Area of Science:
- Colorectal surgery
- Surgical oncology
- Minimally invasive procedures
Background:
- Transanal total mesorectal excision (TaTME) is a novel approach for rectal cancer.
- While safety and feasibility are established, long-term outcome data remain limited.

